跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,638 条关于
“Generalized Myasthenia Gravis”
全部
3,638
临床试验
2,359
药物
80
机构
21
资讯
1,178
去年
Rozanolixizumab Shows Efficacy in Older Adults with Generalized Myasthenia Gravis
去年
RemeGen's Telitacicept Receives Approval in China for Generalized Myasthenia Gravis Treatment
去年
FDA Approves Rystiggo (rozanolixizumab-noli) for Generalized Myasthenia Gravis
2年前
Nipocalimab Shows Sustained Disease Control in Adolescents with Generalized Myasthenia Gravis
去年
Nipocalimab Receives FDA Priority Review for Generalized Myasthenia Gravis Treatment
去年
Handok's Vyvgart Receives Approval for Generalized Myasthenia Gravis Treatment in South Korea
去年
Study Reveals Significant Diagnostic Delays for Minority Patients with Generalized Myasthenia Gravis
9个月前
FDA Approves UPLIZNA as First CD19-Targeted B Cell Therapy for Generalized Myasthenia Gravis
去年
Batoclimab Shows Promising Results in Phase 3 Trial for Generalized Myasthenia Gravis Treatment
去年
Dianthus Therapeutics Completes Enrollment in Phase 2 MaGic Trial for Generalized Myasthenia Gravis Treatment
第 1 页，共 118 页
上一页
下一页
